Eli Lilly and Co. (LLY) Earns Outperform Rating from Credit Suisse Group AG


's stock had its "outperform" rating restated by stock analysts at Credit Suisse Group AG in a report released on Wednesday. They presently have a $87.00 target price on the stock.



from Biotech News